Renal Nerve Denervation(RDN) and Renal Function
Recruiting now
Conditions studied: Effects of RDN on Renal Function
In brief
Current studies have found the efficacy of RDN in the treatment of hypertension, however, the safety of RDN in renal function is still lacking. Therefore, the investigators are aimed to study the effect of RDN on renal function.
Key facts
- Study ID
- NCT05612906
- Run by
- Zhengrong Huang
- People needed
- 50
- Starts
- 2022-06-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-02-27
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18<age≤75 years; 2.clinic blood pressure ≥ 140/90 mmHg or 24-hour ambulatory blood pressure monitoring average blood pressure ≥ 135/85 mmHg after taking 3 or more antihypertensive drugs for more than 4 weeks; 3.essential hypertension, renal parenchymal hypertension, or hypertension patients who are willing to receive RDN ; 4.who signed informed consent and were approved by the Ethics Committee of the First Affiliated Hospital of Xiamen University.
You may not qualify if…
- pregnant women or lactating patients;
- identified secondary hypertension or Pseudo hypertension;
- whose renal arteries were unsuitable for ablation
- obvious bleeding tendency and blood system diseases;
- malignant tumors or end-stage diseases; ⑥Severe peripheral vascular disease, abdominal aortic aneurysm; ⑦A history of the acute coronary syndrome within two weeks; ⑧acute or severe systemic infection; ⑨drug or alcohol dependence or refusal to sign informed consent.
Where it is running
- zhengrong Huang — Xiamen, Fujian, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.